Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,504 public trials 677 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

NCT06888921

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Northwestern Memorial Hospital Warrenville, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 28 locations
View Trial Details
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT06395519

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

NCT07444814

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • UCLA - Hematology/Oncology Clinical Research Unit Los Angeles, California, United States
  • St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

NCT04251052

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 549 locations
View Trial Details
Recruiting

Avera Cancer Sequencing and Analytics Protocol (ASAP)

NCT05142033

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +51 more
Locations
  • Avera Cancer Institute - Marshall Marshall, Minnesota, United States
  • Avera Cancer Institute - Aberdeen Aberdeen, South Dakota, United States
  • Avera Cancer Institute - Mitchell Mitchell, South Dakota, United States
  • Avera Cancer Institute - Pierre Pierre, South Dakota, United States
View Trial Details

Related conditions